Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer

Neoadjuvant chemotherapy (NACT) has been an increasingly used therapeutic strategy to improve the outcome of advanced gastric cancer (GC) over the past few decades. Lymphocytic infiltration has been reported to be associated with response to NACT, but the immune cell subpopulation and its prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kai, Chen, Fuchao, Xie, Huijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913533/
https://www.ncbi.nlm.nih.gov/pubmed/27366089
http://dx.doi.org/10.2147/OTT.S101884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913533/
https://www.ncbi.nlm.nih.gov/pubmed/27366089
http://dx.doi.org/10.2147/OTT.S101884

Ejemplares similares